Menu

Top Stories

Published on Thursday, July 11, 2019

Two years have passed since the liver transplant surgery that saved Jude Ward’s life

Two years have passed since the liver transplant surgery that saved Jude Ward’s life

Almost two years have passed since Nicole and Josef Ward’s son, Jude, had a liver transplant due to Alpha-1 Antitrypsin Deficiency (Alpha-1). You can read that story by clicking here.

Most people diagnosed with Alpha-1 don’t exhibit symptoms until they reach adulthood, when underproduction of the alpha-1 antitrypsin protein leads to complications in the lungs and eventual lung disease, according to the Children’s Organ Transplant Association (COTA). However, Jude was producing an abnormal form of the protein, which started pooling in his liver, damaging it.

By 22 months of age, Jude was experiencing serious liver problems. In December 2016, he was rushed to an emergency room, where doctors said Jude would need a life-saving liver transplant to survive.

The family quickly got Jude onto the waiting list for a liver transplant at a hospital in their native Florida, did seemingly endless research on liver disorders in children, and eventually joined COTA.

The Wards, who now live on the joint base, ended up having better luck seeking a transplant at the Children’s Hospital of Philadelphia.

“On July 6, 2017, at 7 am, we got our first call that the hospital had a possible liver match for Jude,” Nicole Ward recalled. “We spent the entire day at the hospital doing pre-op tests on Jude and making him fast only to find out at 9:30 pm that upon retrieval of the liver it was determined not to be the best match for our Jude. We went back to our temporary transplant home broken more than ever but still clinging to a little hope that Jude’s call would come soon,” she added.

A couple of weeks later, Jude was back in the hospital for complications of his liver disease. By July 19, doctors had found a match for him, and the next day, he had a successful surgery.

“We were very relieved but could not quite let ourselves believe this was the one until he was wheeled into surgery about midnight that same night,” Ward said.

In the months leading up to the surgery, the Wards said Jude’s body was failing him. He could only take in food through a feeding tube, he needed infusions to get rid of excess fluid in his stomach, he was tired all the time but could not sleep comfortably, and he would get bruises and sores that didn’t heal.

Though Jude, now 4, had a successful transplant, it still impacts his life in small ways, as he must make frequent visits to the transplant center for lab work, checkups and adjustments to his immunosuppression medications, his family said.

While the family temporarily lived in Philadelphia at the Gift of Life Family House, COTA was able to raise more than $60,000 for COTA in honor of Jude and his medical expenses.

The family also fears they might go through a similar journey all over again. Their daughter Lucie, born last July, has the same deficiency. She is now in the process of receiving regular lab work to check her liver enzymes and regular ultrasounds.

“We do not know where things are headed with Lucie and a liver transplant, but her doctors are keeping a close eye on her,” Ward said.

“Life after transplant is a balance of enjoying life but also being mindful of keeping Jude healthy. The biggest blessing our family has received is the blessing of perspective,” she finished.

Sources: Burlington County Times, Children’s Organ Transplant Association

Photo courtesy of the Children’s Organ Transplant Association.


Print

Arrowhead completes enrollment in Phase 1 study for treatment of Alpha-1 liver disease

Tuesday, June 19, 2018
Arrowhead Pharmaceuticals, Inc. announced that it has completed enrollment of a Phase 1 clinical trial of ARO-AAT, their second generation subcutaneously administered RNA interference (RNAi) therapeutic that is being developed as a treatment for...
Divider

Alphas will hold one of their biggest meetings in San Francisco

Monday, June 18, 2018
The city of San Francisco, California, will be the site of one of the biggest gatherings of Alphas, when the Alpha-1 Foundation holds, between June 29 – July 1, 2018, its 27th Annual National Education Conference. Alphas – as those...
Divider

New foundation will increase awareness about cell and gene therapy, but caution is recommended

Thursday, June 7, 2018
The Alliance for Regenerative Medicine (ARM) announced the launch of the ARM Foundation for Cell and Gene Medicine, which will be dedicated to increasing public awareness and understanding of the clinical and societal benefits of cell and gene...
Divider

NORD opposes implementation of copay accumulator programs in health plans

Tuesday, June 5, 2018
The National Organization for Rare Disorders (NORD), the nonprofit institution that represents 30 million Americans that suffer from rare diseases, issued the following statement on the increasing use of copay accumulator programs in health...
Divider

RNA interference therapies could be on the verge of success

Tuesday, May 29, 2018
In the mid-2000s there was a wave of excitement across the pharmaceutical industry: a new discovery about cells that had the potential to transform medicine.  “The world became enamored with this idea because it was very powerful. If...
Divider

Consortium seeks common standards for gene-editing therapies

Thursday, May 24, 2018
How to best measure if a therapy is reaching its target gene without introducing errors in others? This is one of the big questions that remain unanswered, as the first CRISPR clinical trials begin in the U.S. and Europe, in 2018. To address...
Divider

2018 research grants on Alpha-1 awarded

Tuesday, May 22, 2018
At a cocktail reception the evening of May 21st, held at The Prado at Balboa Park, within the framework of the American Thoracic Society (ATS) 2018 International Conference in San Diego, California, the Alpha-1 Foundation (A1F) announced the...
Divider

Mark Brantly honored with John W. Walsh PAR Award for Excellence

Monday, May 21, 2018
The Alpha-1 Foundation (A1F) extends a heartfelt message of congratulations to Alpha-1 Antitrypsin Deficiency (Alpha-1) researcher and pioneer, Mark Brantly, MD, for being the first recipient of the newly renamed 2018 John W. Walsh PAR Award for...
Divider

Donohue to receive the Breathing for Life Award

Friday, May 18, 2018
James F. Donohue, MD, will be honored with the Breathing for Life Award at the Tenth Annual American Thoracic Society (ATS) Foundation Research Program Benefit on Saturday, May 19th, 2018, in San Diego, California. The Award is the highest honor...
Divider

Alpha Jonathan Maidment hikes the Pacific Crest Trail

Thursday, May 17, 2018
This story appears in the Spring 2018 issue of Alpha-1-To-One Magazine. Subscriptions are free. Determined and driven are the first two adjectives that come to mind when you get a grasp of the endeavor that 23-year-old Jonathan Maidment has...
Divider

Spring has built new friends to find a cure

Thursday, May 17, 2018
The Building Friends for a Cure (BFC) program was created by the Alpha-1 Foundation (A1F) to make new friends and nurture those friendships throughout the year, because we cannot do it alone, you are all needed! Pictured: George Washington...
Divider

FDA files lawsuits to stop unapproved stem cell therapies

Wednesday, May 16, 2018
The Food and Drug Administration (FDA) is seeking court orders to stop several institutions and doctors from using unapproved stem cell treatments and therapies on their patients which, in some cases, have caused serious harm. The FDA filed two...
Divider
First45678910111213Last

Article Search

Enter keywords in text box and click Search button for results.

Archive